In the first agreement, Medivir has outlicensed its preclinical human immunodeficiency virus (HIV) protease inhibitor project and in the second agreement provided a license for the MIV-210 polymerase inhibitor compound for HIV and hepatitis B (HBV).
What does PI stand for?
PI stands for Protease Inhibitor
This definition appears very frequently and is found in the following Acronym Finder categories:
- Science, medicine, engineering, etc.
See other definitions of PI
We have 126 other meanings of PI in our Acronym Attic
- Project Identification (number)
- Project Impact (various organizations)
- Project Inspector (various locations)
- Projector Infantry
- Projets Individuels
- Propidium Iodide
- Proportional-Integral (controller)
- Propriedade Intelectual (Intellectual Property, Brazil)
- Proprietary Information
- Prospective Internationale
Samples in periodicals archive:
Prezista (also called darunavir, or TMC-114), a new protease inhibitor active against many of the viruses resistant to other protease inhibitors, was approved by the FDA on June 23 "for the treatment of human immunodeficiency virus (HIV) infection in antiretroviral treatment-experienced adult patients, such as those with HIV-1 strains resistant to more than one protease inhibitor.
It has been almost 10 years since the approval of the first protease inhibitor (Invirase) in December 1995.
That human trial was only a few days long, however, and questions remain about whether the particular protease inhibitor tested is safe for long-term use.
1) Furthermore, women who take protease inhibitors as part of their combined drug regimen are no more likely to have a premature or very premature delivery or a low-birth-weight infant than are women who use combination therapy without these drugs, monotherapy or no therapy.
BARCELONA, SPAIN -- Treatment with a protease inhibitor boosted the risk of a myocardial infarction by more than sevenfold in patients infected with HIV.
BARCELONA, SPAIN -- Treatment with a protease inhibitor was generally safe for pregnant women and their infants, based on a retrospective review of 233 pregnant women who received the drug.
So he's decided not to take the newest and most promising AIDS drugs to date: protease inhibitors (see diagram, left).